Karyopharm to Participate at Upcoming Investor Conferences
/PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
Source: prnewswire.com
Page 22 - Nuclear Export News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nuclear Export Today - Breaking & Trending Today
UAE highlights its robust Nuclear Safeguards Regime
UAE demonstrates commitments to conventions to ensure the peaceful of nuclear energy
Source: gulfnews.com
Karyopharm Therapeutics (KPTI) Q3 2022 Earnings Call Transcript
KPTI earnings call for the period ending September 30, 2022.
Source: fool.com
Karyopharm Announces New Selinexor Data in Myelofibrosis and Multiple Myeloma to be Presented at ASH 2022
– Encouraging Data Observed in Phase 1 Study of Selinexor in Combination with Ruxolitinib in Treatment-Naïve Myelofibrosis, Including Activity Across Three Key...
Source: prnewswire.com
Karyopharm Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
– Achieved Third Quarter 2022 Total Revenue of $36.1 Million, Including XPOVIO® (selinexor) Net Product Revenue of $32.0 Million, a 20 % Increase Over Third...
Source: prnewswire.com